Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
Verlinvest Beverages SA, reporting as an officer of Vita Coco Company, Inc. (COCO), sold 3,000,000 shares of the issuer's common stock on 09/17/2025 at a price of $40.77 per share. The filing lists 4,097,161 shares beneficially owned following the transaction, held directly. The sale is described as a block sale executed under Rule 144 to an unaffiliated financial institution. The Form 4 is signed by Axelle Henry on 09/19/2025 and indicates the reporting person is a former 10% owner and an officer.
Verlinvest Beverages SA, reporting as an officer of Vita Coco Company, Inc. (COCO), sold 3,000,000 shares of the issuer's common stock on 09/17/2025 at a price of $40.77 per share. The filing lists 4,097,161 shares beneficially owned following the transaction, held directly. The sale is described as a block sale executed under Rule 144 to an unaffiliated financial institution. The Form 4 is signed by Axelle Henry on 09/19/2025 and indicates the reporting person is a former 10% owner and an officer.
Martin Roper, a director and the CEO of Vita Coco Company, Inc. (COCO), reported multiple sales of common stock on September 16–17, 2025 effected under a Rule 10b5-1 trading plan. The Form 4 shows both direct and indirect dispositions: direct sales by the reporting person and sales of shares held in related family trusts. Prices reported are weighted averages around $40.00–$40.54 per share. The filing also discloses substantial stock option holdings that are largely vested and exercisable at strike prices ranging from $10.178 to $32.78, with multiple option grants representing significant potential common shares.
Martin Roper, a director and the CEO of Vita Coco Company, Inc. (COCO), reported multiple sales of common stock on September 16–17, 2025 effected under a Rule 10b5-1 trading plan. The Form 4 shows both direct and indirect dispositions: direct sales by the reporting person and sales of shares held in related family trusts. Prices reported are weighted averages around $40.00–$40.54 per share. The filing also discloses substantial stock option holdings that are largely vested and exercisable at strike prices ranging from $10.178 to $32.78, with multiple option grants representing significant potential common shares.
Martin Roper, a director and the CEO of Vita Coco Company, Inc. (COCO), reported multiple sales of common stock on September 16–17, 2025 effected under a Rule 10b5-1 trading plan. The Form 4 shows both direct and indirect dispositions: direct sales by the reporting person and sales of shares held in related family trusts. Prices reported are weighted averages around $40.00–$40.54 per share. The filing also discloses substantial stock option holdings that are largely vested and exercisable at strike prices ranging from $10.178 to $32.78, with multiple option grants representing significant potential common shares.
Corey Baker, listed as Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported a series of transactions on 09/16/2025–09/18/2025. The filings show three separate acquisitions of 1,000 shares each at $16.91 and three corresponding sales of 1,000 shares each at $40. After those transactions the reporting person held 38,754 shares of common stock.
The Form 4 also discloses exercises or holdings of multiple non-qualified stock options with strike prices ranging from $16.91 to $33.36 covering in aggregate thousands of underlying shares (for example, 13,481 shares at $24.35 and 13,218 shares at $33.36). The sales of common stock were effected pursuant to a Rule 10b5-1 trading plan, as stated in the filing.
Corey Baker, listed as Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported a series of transactions on 09/16/2025–09/18/2025. The filings show three separate acquisitions of 1,000 shares each at $16.91 and three corresponding sales of 1,000 shares each at $40. After those transactions the reporting person held 38,754 shares of common stock.
The Form 4 also discloses exercises or holdings of multiple non-qualified stock options with strike prices ranging from $16.91 to $33.36 covering in aggregate thousands of underlying shares (for example, 13,481 shares at $24.35 and 13,218 shares at $33.36). The sales of common stock were effected pursuant to a Rule 10b5-1 trading plan, as stated in the filing.
Form 144 notice filed for Vita Coco Company, Inc. (COCO). The filer intends to sell 3,000,000 shares of common stock through Morgan Stanley & Co. LLC on or about 09/17/2025, with an aggregate market value of $126,900,000. The shares were acquired on 12/21/2016 via a pre-IPO investment originally held by Verlinvest SA and later transferred to Verlinvest Beverages SA; payment was in cash. The issuer has 56,822,981 shares outstanding per the filing. The notice states there were no securities sold by the reporting person in the past three months and includes the required representation that the selling person is not aware of undisclosed material adverse information.
Form 144 notice filed for Vita Coco Company, Inc. (COCO). The filer intends to sell 3,000,000 shares of common stock through Morgan Stanley & Co. LLC on or about 09/17/2025, with an aggregate market value of $126,900,000. The shares were acquired on 12/21/2016 via a pre-IPO investment originally held by Verlinvest SA and later transferred to Verlinvest Beverages SA; payment was in cash. The issuer has 56,822,981 shares outstanding per the filing. The notice states there were no securities sold by the reporting person in the past three months and includes the required representation that the selling person is not aware of undisclosed material adverse information.
Vita Coco Company, Inc. (COCO) filed a Form 144 reporting proposed sale of 20,000 common shares following an exercise of stock options on the same day. The securities are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value reported as $799,600 and approximately 56,822,981 shares outstanding. The filer reports the acquisition and payment occurred on 09/17/2025 (cash payment), and discloses a recent 10b5-1 sale of 10,000 shares on 09/12/2025 generating $400,032 in gross proceeds. The filing includes the usual representation about absence of undisclosed material information.
Vita Coco Company, Inc. (COCO) filed a Form 144 reporting proposed sale of 20,000 common shares following an exercise of stock options on the same day. The securities are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value reported as $799,600 and approximately 56,822,981 shares outstanding. The filer reports the acquisition and payment occurred on 09/17/2025 (cash payment), and discloses a recent 10b5-1 sale of 10,000 shares on 09/12/2025 generating $400,032 in gross proceeds. The filing includes the usual representation about absence of undisclosed material information.
Vita Coco Company, Inc. (COCO) notice records a proposed sale under Rule 144 and recent 10b5-1 transactions by an insider. The filer plans to sell 20,000 common shares through Morgan Stanley Smith Barney at an aggregate market value of $799,600, representing securities outstanding of 56,822,981 shares, with an approximate sale date of 09/17/2025.
The securities were acquired on 09/17/2025 by exercise of stock options and paid in cash. The filing also discloses two prior 10b5-1 sales this year: 10,000 shares on 07/07/2025 for $380,178 and 10,000 shares on 09/12/2025 for $400,019.
Vita Coco Company, Inc. (COCO) notice records a proposed sale under Rule 144 and recent 10b5-1 transactions by an insider. The filer plans to sell 20,000 common shares through Morgan Stanley Smith Barney at an aggregate market value of $799,600, representing securities outstanding of 56,822,981 shares, with an approximate sale date of 09/17/2025.
The securities were acquired on 09/17/2025 by exercise of stock options and paid in cash. The filing also discloses two prior 10b5-1 sales this year: 10,000 shares on 07/07/2025 for $380,178 and 10,000 shares on 09/12/2025 for $400,019.
Form 144 notice for Vita Coco Company, Inc. (COCO) shows a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,999,000, with an approximate sale date of 09/17/2025. The shares were acquired as founders shares on 09/10/2010. The filing also reports two recent 10b5-1 sales by the MICHAEL KIRBAN 2010 TRUST: 20,000 shares sold on 09/11/2025 for $780,898 and 30,000 shares sold on 09/09/2025 for $1,174,821. There are 56,822,981 shares outstanding reported on the form. The filer affirms compliance representations required under Rule 144 and 10b5-1 trading-plan attestations.
Form 144 notice for Vita Coco Company, Inc. (COCO) shows a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,999,000, with an approximate sale date of 09/17/2025. The shares were acquired as founders shares on 09/10/2010. The filing also reports two recent 10b5-1 sales by the MICHAEL KIRBAN 2010 TRUST: 20,000 shares sold on 09/11/2025 for $780,898 and 30,000 shares sold on 09/09/2025 for $1,174,821. There are 56,822,981 shares outstanding reported on the form. The filer affirms compliance representations required under Rule 144 and 10b5-1 trading-plan attestations.
Vita Coco Company, Inc. (COCO) filing a Form 144 notifies the proposed sale of 10,000 common shares through Morgan Stanley Smith Barney on 09/17/2025 with an aggregate market value of $399,800.00. The shares were acquired and paid for on 09/17/2025 by exercise of stock options, with payment in cash. The filer also reported three prior 10b5-1 sales this year totaling 30,000 shares on 06/18/2025, 07/01/2025 and 09/12/2025, with gross proceeds shown for each sale.
Vita Coco Company, Inc. (COCO) filing of Form 144 reports a proposed sale of 21,700 common shares by an insider acquired as stock compensation on 07/12/2016. The filing lists the broker as The Charles Schwab Corporation and shows an aggregate market value of $1,068,399.00 for the proposed sale with an approximate sale date of 09/17/2025 on NASDAQ. The filer also disclosed two prior sales by the same person totaling 7,800 shares during July and August 2025 that generated combined gross proceeds of $285,088.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), reported transactions dated 09/12/2025 on Form 4. He exercised a stock option to acquire 10,000 shares at an exercise price of $10.178 per share and simultaneously sold 10,000 shares under a Rule 10b5-1 plan at a weighted average price of $40.002 per share. After these transactions his beneficial ownership is reported as 84,328 shares. The filing itemizes multiple outstanding non-qualified stock options with exercise prices ranging from $10.178 to $33.36 and various vesting schedules; some options are fully vested and exercisable. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/16/2025.